Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells. It is not
yet known which chemotherapy regimen is more effective for advanced Hodgkin's disease.
PURPOSE: Randomized phase III trial to compare different combination chemotherapy regimens in
treating patients with advanced Hodgkin's disease.